Sign Out
Plaque psoriasis: Adults: Guselkumab (Tremfya) by subcutaneous (SC) administration is indicated for: treatment of plaque psoriasis; treatment of scalp psoriasis, nail psoriasis, and hand and foot psoriasis; improvement of health related quality of life in adult patients with moderate to severe psoriasis who are candidates for phototherapy or systemic therapy.
Psoriatic arthritis: Guselkumab (Tremfya) is indicated for the treatment of adult patients with active psoriatic arthritis.
Palmoplantar pustulosis: Guselkumab (Tremfya) by subcutaneous (SC) administration is indicated for the treatment of palmoplantar pustulosis (PPP) in adult patients who do not adequately respond to conventional therapy.
Continue with Google